Castle Carpentry and Cladding’s Post

Great news again for Cork as Hovione has officially commissioned an expansion at its manufacturing facility in Ringaskiddy. This new multi-million euro investment almost doubles the capacity of their spray drying facilities in Ireland and will create more than 20 new positions. Dr. Jean-Luc Herbeaux Hovione's chief executive said: “This newly opened facility further strengthens Hovione's position as the global CDMO of choice for spray drying development and manufacturing services."

https://lnkd.in/dJeZ2KVk Breaking Ground in Pharma Supply Chain: Check out our latest article on The Wolf Practice website, diving deep into the game-changing strategies for tackling serialization challenges! 🚀 💼 #PharmaInnovation #SupplyChainSolutions #TheWolfPractice

🎉 Victory after 12 years of patent battles: Novozymes (now Novonesis) prevails over DSM 🎉 Lactose-free dairy products have become a staple in supermarkets worldwide, but behind the scenes, a fierce legal battle has been unfolding for over a decade. Since 2012, Novozymes (now Novonesis) has been involved in a highly complex patent dispute with DSM over a crucial lactose-removing enzyme. This journey involved: The revocation or refusal of six patent applications/patents by the European Patent Office (EPO). A cross-border preliminary injunction granted across multiple states, which was later lifted following the revocation of the parent patent. After years of perseverance and legal challenges, the final case has now been resolved with the Boards of Appeal revoking DSM’s last patent. This marks the end of an extraordinary chapter in patent dispute. We are incredibly proud to have supported Novozymes throughout this arduous process. Their stamina and determination in securing freedom-to-operate and fair competition are truly commendable. Our partner Hendrik Wichmann and collaborator Simon Mügge were relentlessly fighting for the client throughout these years. 💡 This case highlights the complexities of intellectual property disputes and the importance of resilience in patent disputes. #PatentLaw #LactoseFree #Novonesis #IP #Novozymes

Next up it's a dual dialogue session at the Pharma and Biotech Patent Litigation NA event here in Philly. The Cellect case has been a recurring topic today, but now we’re diving deep into its impact on Patent Term Extension (PTE) and Patent Term Adjustment (PTA) calculations. 📊 A huge thank you to our speakers for sharing their expertise and shedding light on the complexities of this landmark case: Martina Hufnal (Fish & Richardson P.C.) Bart Newland (Atalanta Therapeutics) #PatentTermExtension #PatentTermAdjustment #CellectCase #PharmaPatent #BiotechPatent #IPLaw

Thoughts on this? >> Oaktree creates third life sciences SPAC, following success with Hims & Hers and Alvotech >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #productmarketing #biotech #pharmaceutical #healthcare

Next week our life science experts are heading to this year’s World Biosimilar Congress in Basel. Are you attending? If so, catch our very own Gina Bicknell and Natalie Coan speaking about Issues in Biosimilar Licensing Transactions, plus Tracey Roberts and Marc Jarvis will join the panel discussion on Big Changes in the Regulatory and Patent Landscape. The team look forward to connecting. #LifeSciences #PatentLaw #Biosimilars

Our colleagues from ITENE (Pau Camilleri Lledó & team), as Safe-and-Sustainable-by-Design (#SSbD) experts, will establish a comprehensive SSbD approach and contribute to the harmonization and standardization of new methodologies and protocols developed within SSbD4CheM. Additionally, ITENE´s LCA experts (Fruela Pérez Sánchez & team) will head efforts to improve, develop, and validate an innovative methodology for ex-ante Life Cycle Assessment (#LCA), as well as evaluate the socio-economic sustainability of chosen use cases!

BcFG is coming closer to reality everyday. 1. Land purchase is nearing completion -> will start building. 2. CDMO of interest identified for particular drug formulations and administration routes. 3. Potential venture capitol investors communicating with. 4. Business is set to become a reality once Land purchase is closed. 5. Trademark and copyright will be next. 6. Licensing of the patent to BcFG from myself. 7. Finalization of venture capitol and CDMO partners. 8. Clinical trials 9. FDA approval 10. Market - We will also be selling antiseptics without FDA approval meant for surface disinfection.(but if you chose to use them on yourself could work as a topical, but would be strongly discouraged) #BcFG #antibiotics #antiseptics #business #venturecapitol #venture #money #funding #invest #investment #changetheworld #licensing #clinicaltrials #drugs #steps #stepbystep #makingprogress #alwaysprogressing

Thoughts on this? >> Oaktree creates third life sciences SPAC, following success with Hims & Hers and Alvotech >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #productmarketing #healthcare

The Ninth Circuit's decision in Lytle v. Nutramax Labs, Inc. allows plaintiffs to use a proposed damages model to show that damages can be measured, even if the model hasn't been executed. This means plaintiffs only need to demonstrate the potential for common proof at the class certification stage. However, the ruling also outlines the challenges plaintiffs face and how defendants can contest class certification by questioning the reliability and assumptions of these models. Stay informed - https://bit.ly/4ea0nRG #LegalUpdate #ClassAction #NinthCircuit #LitigationNews